Author Information
Zekaver Odabaşı is a distinguished researcher affiliated with the Department of Infectious Diseases and Clinical Microbiology at the School of Medicine, Marmara University, located in Pendik/Istanbul, Turkey. Zekaver Odabaşı has contributed significantly to the understanding and treatment of infectious diseases, particularly in the context of COVID-19. The affiliation details suggest a strong connection with a reputable institution, indicating a well-established career in the field.Research Contributions
Zekaver Odabaşı has made substantial contributions to the field of infectious diseases, with a particular focus on COVID-19. Notable works include studies on the treatment of severe COVID-19 with tocilizumab, the use of CALL scores to predict COVID-19 progression, and the exploration of liver stiffness in relation to COVID-19 severity. Additionally, Odabaşı has researched other infections such as Cryptococcus meningitis, Staphylococcus aureus, and Candida urinary tract infections, showcasing a broad interest and expertise in infectious diseases.Aliases
Zekaver Odabaşı is also known by several aliases, including Z. Odabasi, Zekaver Odabaşi, and Zekaver Odabası. These variations may appear in different publications or databases.Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
1850 |
| H-index |
16 |
| Paper Count |
46 |
